RMEBX
Price
$55.73
Change
+$0.45 (+0.81%)
Updated
Dec 24 closing price
SUSYX
Price
$14.15
Change
+$0.10 (+0.71%)
Updated
Dec 24 closing price
Ad is loading...

RMEBX vs SUSYX

Header iconRMEBX vs SUSYX Comparison
Open Charts RMEBX vs SUSYXBanner chart's image
American Funds American Mutual R2E
Price$55.73
Change+$0.45 (+0.81%)
VolumeN/A
CapitalizationN/A
SEI US Managed Volatility Y (SIMT)
Price$14.15
Change+$0.10 (+0.71%)
VolumeN/A
CapitalizationN/A
RMEBX vs SUSYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMEBX vs. SUSYX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and SUSYX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 103B vs. SUSYX (592M). SUSYX pays higher dividends than RMEBX: SUSYX (1.86) vs RMEBX (1.54). RMEBX was incepted earlier than SUSYX: RMEBX (10 years) vs SUSYX (10 years). SUSYX is a more actively managed with annual turnover of: 49.00 vs. RMEBX (25.00). RMEBX has a lower initial minimum investment than SUSYX: RMEBX (250) vs SUSYX (100000). RMEBX annual gain was more profitable for investors over the last year : 11.90 vs. SUSYX (2.61). RMEBX return over 5 years is better than : 38.18 vs. SUSYX (-13.83).
RMEBXSUSYXRMEBX / SUSYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years10 years-
Gain YTD11.1532.229500%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets103B592M17,399%
Annual Yield % from dividends1.541.8683%
Returns for 1 year11.902.61456%
Returns for 3 years11.77-12.18-97%
Returns for 5 years38.18-13.83-276%
Returns for 10 years58.99N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRNS0.260.02
+8.07%
Marinus Pharmaceuticals
EXPD111.190.69
+0.62%
Expeditors International of Washington
PRTA15.400.07
+0.46%
Prothena Corp
FATE1.66N/A
N/A
Fate Therapeutics
RNG36.99-0.36
-0.96%
RINGCENTRAL